Title : Serum Copeptin and Zinc-α2-glycoprotein Levels Are Novel Biomarkers of Tolvaptan Treatment in Decompensated Cirrhotic Patients with Ascites.

Pub. Date : 2021

PMID : 34719623






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Serum Copeptin and Zinc-alpha2-glycoprotein Levels Are Novel Biomarkers of Tolvaptan Treatment in Decompensated Cirrhotic Patients with Ascites. Tolvaptan arginine vasopressin Homo sapiens
2 Conclusion Serum BUN, copeptin and ZAG levels predict the patient response to tolvaptan, even when measured prior to treatment. Tolvaptan arginine vasopressin Homo sapiens